1. Home
  2. LGIH vs NNNN Comparison

LGIH vs NNNN Comparison

Compare LGIH & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$47.83

Market Cap

1.2B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$26.06

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGIH
NNNN
Founded
2003
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2013
2025

Fundamental Metrics

Financial Performance
Metric
LGIH
NNNN
Price
$47.83
$26.06
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$71.13
N/A
AVG Volume (30 Days)
330.9K
26.9K
Earning Date
11-04-2025
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.53
0.06
Revenue
$1,788,933,000.00
$8,185,146.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17.77
N/A
P/E Ratio
$10.74
$534.57
Revenue Growth
N/A
21.95
52 Week Low
$39.70
$5.18
52 Week High
$104.31
$55.65

Technical Indicators

Market Signals
Indicator
LGIH
NNNN
Relative Strength Index (RSI) 46.65 46.07
Support Level $46.73 $26.89
Resistance Level $50.54 $44.73
Average True Range (ATR) 2.17 5.72
MACD -0.36 -0.32
Stochastic Oscillator 10.77 22.84

Price Performance

Historical Comparison
LGIH
NNNN

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: